New irreversible adenosine A(1) antagonists based on FSCPX.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Adenosine Receptor Research

Background:

• FSCPX and its amide analogue are known potent and selective irreversible antagonists of the A(1) adenosine receptor (A(1)AR) in vitro.
• Existing A(1)AR antagonists may have limitations in stability for certain applications.

Purpose of the Study:

• To synthesize novel analogues of FSCPX with enhanced stability.
• To explore the incorporation of a 4-(fluorosulfonyl)phenyl moiety linked via a ketone to the xanthine pharmacophore.
• To evaluate the affinity and irreversible binding characteristics of the new compounds to the A(1)AR.

Main Methods:

• Synthesis of FSCPX analogues incorporating a ketone linkage and a 4-(fluorosulfonyl)phenyl group.
• In vitro assessment of compound affinity for the A(1) adenosine receptor.
• Evaluation of concentration-dependent irreversible binding to the A(1)AR.

Main Results:

• Novel analogues (compounds 4a-c) were synthesized and characterized.
• These compounds demonstrated improved affinity for the A(1) adenosine receptor compared to previous agents.
• Compounds 4a-c exhibited concentration-dependent irreversible binding, confirming their antagonist activity.

Conclusions:

• The developed FSCPX analogues possess enhanced stability and potent irreversible antagonism of the A(1)AR.
• The ketone linkage effectively connects the chemoreactive moiety to the xanthine core, improving A(1)AR antagonism.
• These findings provide a foundation for developing more stable and effective A(1)AR antagonists for therapeutic use.